United Capital Financial Advisors LLC Acquires Shares of 6,154 Agilent Technologies, Inc. $A

United Capital Financial Advisors LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,154 shares of the medical research company’s stock, valued at approximately $817,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Core Wealth Advisors LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $26,000. SHP Wealth Management purchased a new stake in shares of Agilent Technologies in the fourth quarter worth about $26,000. Navalign LLC acquired a new stake in Agilent Technologies during the fourth quarter worth about $27,000. Cedar Mountain Advisors LLC purchased a new position in Agilent Technologies during the first quarter valued at approximately $27,000. Finally, MV Capital Management Inc. acquired a new position in Agilent Technologies in the fourth quarter valued at approximately $28,000.

Key Agilent Technologies News

Here are the key news stories impacting Agilent Technologies this week:

• Positive Sentiment: Agilent reported fiscal Q3 earnings of $1.62 per share, above the $1.48-$1.49 analyst consensus, while revenue of approximately $1.88 billion also exceeded expectations. EPS increased from $1.37 a year earlier, supporting the view that profitability is improving. Agilent Technologies Q3 Earnings and Revenues Top Estimates
• Positive Sentiment: Management raised its full-year guidance following the strong quarter. Commentary highlighted product momentum, a recovery in China, improving demand and expanding margins, all of which could support additional earnings growth. Agilent Technologies Lifts Outlook After Strong Quarter
• Positive Sentiment: Several major firms raised their price targets and maintained bullish ratings after the results. Targets now range from $175 to $190, with upgrades from JPMorgan, Citi, Barclays, Goldman Sachs, Bank of America, Stifel, TD Cowen, Bernstein and RBC. Analysts Raise Agilent Technologies Price Targets
• Neutral Sentiment: Despite the improved outlook, valuation remains relatively demanding: Agilent trades at roughly 30 times earnings, with a PEG ratio above 2.7. This leaves the stock sensitive to any slowdown in demand or disappointment in future guidance.

Agilent Technologies Stock Up 0.4%

NYSE A opened at $154.47 on Monday. The business has a fifty day moving average price of $140.30 and a 200 day moving average price of $127.04. Agilent Technologies, Inc. has a one year low of $108.35 and a one year high of $163.75. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.56 and a current ratio of 2.05. The company has a market cap of $43.63 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.34 and a beta of 1.25.

Agilent Technologies (NYSE:A) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. The business had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Research analysts anticipate that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Citigroup boosted their target price on shares of Agilent Technologies from $185.00 to $190.00 and gave the company a “buy” rating in a research note on Thursday. Bank of America raised their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company a “buy” rating in a research report on Thursday. Piper Sandler initiated coverage on shares of Agilent Technologies in a report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 price objective for the company. Morgan Stanley increased their target price on shares of Agilent Technologies from $160.00 to $175.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. Finally, The Goldman Sachs Group raised their target price on Agilent Technologies from $155.00 to $175.00 and gave the company a “buy” rating in a research report on Thursday. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average price target of $170.33.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.